Status:
COMPLETED
Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Conditions:
Smoking
Tobacco Use
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of the study is to pilot test a multi-modal smoking cessation and relapse prevention intervention with the lung cancer patient population and to obtain preliminary data on its feasibility.
Eligibility Criteria
Inclusion
- 18 years of age or older
- Smoked at least 100 cigarettes in lifetime
- Current smoking (defined as self-report of any smoking, even a puff, in the past 30 days)
- Diagnosis of lung cancer
- Able to read and write English
- Not currently enrolled in a smoking cessation program
- Has a working telephone
- Has a valid home address
Exclusion
- Current use of tobacco cessation medications
- Another household member enrolled in this study
- Contraindication of nicotine patch, unless under the supervision of a physician as advised by project staff
- Moffitt clinical trial participant at time of enrollment
Key Trial Info
Start Date :
June 7 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 28 2023
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT05362318
Start Date
June 7 2021
End Date
January 28 2023
Last Update
October 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Moffitt Cancer Center
Tampa, Florida, United States, 33617